4-105275662-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001127208.3(TET2):​c.5152G>T​(p.Val1718Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00651 in 1,551,956 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0043 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0068 ( 31 hom. )

Consequence

TET2
NM_001127208.3 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: -0.0290

Publications

26 publications found
Variant links:
Genes affected
TET2 (HGNC:25941): (tet methylcytosine dioxygenase 2) The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
TET2-AS1 (HGNC:41125): (TET2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0058729947).
BP6
Variant 4-105275662-G-T is Benign according to our data. Variant chr4-105275662-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 135297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00427 (650/152322) while in subpopulation NFE AF = 0.00705 (480/68038). AF 95% confidence interval is 0.00653. There are 4 homozygotes in GnomAd4. There are 276 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TET2NM_001127208.3 linkc.5152G>T p.Val1718Leu missense_variant Exon 11 of 11 ENST00000380013.9 NP_001120680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TET2ENST00000380013.9 linkc.5152G>T p.Val1718Leu missense_variant Exon 11 of 11 5 NM_001127208.3 ENSP00000369351.4

Frequencies

GnomAD3 genomes
AF:
0.00427
AC:
650
AN:
152204
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00536
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00705
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00361
AC:
569
AN:
157498
AF XY:
0.00365
show subpopulations
Gnomad AFR exome
AF:
0.000977
Gnomad AMR exome
AF:
0.00117
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00497
Gnomad NFE exome
AF:
0.00668
Gnomad OTH exome
AF:
0.00247
GnomAD4 exome
AF:
0.00675
AC:
9450
AN:
1399634
Hom.:
31
Cov.:
32
AF XY:
0.00652
AC XY:
4502
AN XY:
690306
show subpopulations
African (AFR)
AF:
0.00101
AC:
32
AN:
31598
American (AMR)
AF:
0.00123
AC:
44
AN:
35708
Ashkenazi Jewish (ASJ)
AF:
0.000159
AC:
4
AN:
25180
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.00126
AC:
100
AN:
79236
European-Finnish (FIN)
AF:
0.00557
AC:
275
AN:
49388
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5698
European-Non Finnish (NFE)
AF:
0.00806
AC:
8697
AN:
1078998
Other (OTH)
AF:
0.00511
AC:
297
AN:
58090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
566
1132
1699
2265
2831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00427
AC:
650
AN:
152322
Hom.:
4
Cov.:
32
AF XY:
0.00371
AC XY:
276
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41572
American (AMR)
AF:
0.00196
AC:
30
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4822
European-Finnish (FIN)
AF:
0.00536
AC:
57
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00705
AC:
480
AN:
68038
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
34
68
101
135
169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00587
Hom.:
20
Bravo
AF:
0.00399
TwinsUK
AF:
0.00971
AC:
36
ESP6500AA
AF:
0.000723
AC:
1
ESP6500EA
AF:
0.00660
AC:
21
ExAC
AF:
0.00266
AC:
68
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TET2: BP4, BS2

May 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TET2-related disorder Benign:1
Mar 09, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.25
DANN
Benign
0.41
DEOGEN2
Benign
0.010
T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
LIST_S2
Benign
0.61
T;T;.
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0059
T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.0
.;L;L
PhyloP100
-0.029
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.34
N;N;N
Sift
Benign
0.38
T;T;T
Sift4G
Benign
1.0
T;T;T
Vest4
0.044
ClinPred
0.00035
T
GERP RS
-2.3
Varity_R
0.018
gMVP
0.30
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142312318; hg19: chr4-106196819; COSMIC: COSV54398060; API